Yifan Yuan1, Qi Yue1, Xiang Zou1, Jiajun Cai1, Ying-Hua Chu2, Yi-Cheng Hsu2, Patrick Alexander Liebig3, Hui Zhang4, He Wang4, Liang Chen1, and Ying Mao1
1Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China, 2MR Collaboration, Siemens Healthcare Ltd., Shanghai, China, 3Siemens Healthcare GmbH, Erlangen, Germany, 4Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China
Synopsis
Preoperative
assessment of histological grades and possible margin of glioma are challenges
to neurosurgeons, which may also make a huge difference in therapeutic
strategies. In this study, we aim to establish a grade-discrimination criterion
via APT and explore the possible metastatic margin of diffuse glioma at 7T.
Eleven patients underwent
structural imaging and APT CEST imaging. Results of the APT were merged
with the T1 image, which showed a promising indication of preoperative
histological grades. Meanwhile, with the early exploration of metastatic
margin, the APT CEST at 7 Tesla may significantly facilitate the surgical
strategy and surgical excision extension.
Introduction
Glioma is the most
common malignant intradural tumor, with an incidence of about 6 per 100,0001. WHO grade IV
glioblastoma accounts for more than 50% of all gliomas and has the highest
degree of malignancy. The median survival time after surgical resection
combined with radiotherapy and chemotherapy is only 14-16 months. After
treatment with tumor electric field, the median survival time only improves to
20.1 months2.
How to improve the treatment effect of glioma is an eternal topic for
multidisciplinary clinicians such as neurosurgeons, oncologists, and
radiologists. Despite the constant developing treatment, surgery is the effective
way and the most critical step in the comprehensive treatment of gliomas. It is
important to establish a good preoperative diagnosis and boundary determination
for guiding surgery. Chemical Exchange Saturation Transfer (CEST) of amide
protons has been increasingly employed for tumor grading3. In this study, we attempt to use the 7T
to differentiate LGG (WHO Grade I and II) from HGG (WHO Grade
III and IV) and to explore the
possible metastatic margin, combining neuro-navigational system to guiding the
surgical strategy.Material and methods
The study was approved by the local
institutional ethics committee, and written informed consent was obtained from
all patients. A total of eleven patients (seven females, four males; median age, 46 years; age range, 28–60 years; see Table 1) were recruited with the inclusion
criteria of (1) a suspected intracranial occupying lesion on routine MRI; (2)
had surgical resection with histological examination. All
of the patients underwent surgical biopsy or resection for definitive
histopathologic diagnoses.
All patients were scanned at a 7 T MRI
scanner (MAGNETOM Terra, Siemens Healthineers, Erlangen, Germany). MP2RAGE (TR=3800
ms, TI1=800ms, TI2=2700ms, TE=2.29ms, FA=7°,and resolution=0.7mm isotropic) and T2-Flair (TR=9000ms, TI=2600ms, TE=274ms,
FA=120°, and resolution=0.8 mm isotropic) were
acquired. The APT CEST data (TR=3.4ms, TE=1.59ms, FA=6°,and resolution=1.6mm x 1.6mm x 5mm, 56 RF offsets, B1=0.6, 0.75, 0.9mT) were calculated using the Lorentzian
fit method4 with B1 correction. Region of interest (ROI) was drawn on T1-weighted axial
slices within the glioma lesion (Figure 1). The 90th percentile of the APT-CEST distribution within each patient's ROI
was used for statistical analysis.Results
Figure
1 shows the T2-Flair images, T1 images, ROIs, and APT in a patient. There were
two tumor lesions with different grades (The top row is from WHO Grade IV, and
the bottom row is from WHO Grade II). Larger APT values can be found in the
high-grade region (5.63%) compare to high-grade region (6.29%). The mean and
standard deviation of the APT among all patients were calculated in WHO grade
II, grade III, and grade IV: 4.87 ± 0.73, 5.94 ± 1.63, and 6.05 ± 1.12. The APT-CEST signal increased when the WHO
grade was higher. In Figure 2A, the APT-CEST signal was significantly higher in
HGG than in LGG (p-value <0.05). The IDH mutation status (a significant
molecular biomarker5 of predicting the prognosis) in each patient was classified
by WHO (Figure 2B). The APT-CEST signal of patients without and with IDH
mutation were respectively
4.79 ±
1.19 and 4.93 ±
0.59 in WHO grade II, and 6.29 ± 1.13 and 5.09 ± n/a in WHO grade IV. There were two biopsy locations in subject 15 in the
margin and core of the lesion in left frontal (the biopsy path is shown in Figure
3). The pathology of the first location of biopsy (figure 3A) is gliosis
with mild abnormal in nuclear with a pathologic diagnose as possible low-grade
glioma; while the second biopsy position (figure 3B) was diagnosed as
anaplastic astrocytoma (WHO grade III). The degradation of pathologic features shown there
may exist a possible metastatic margin in the edema of glioma especially in
HGG, which could be a revolution of the strategy to glioma surgery:” Metabolic Resection”. Discussion and conclusion
Higher APT-CEST signal in
HGG compared to LGG was found. Finding the edge lesion can be challenging. The
edema in HGG can obscure the ROI definition, which can cause larger deviation. We use 90th percentile data within the
ROI to reduce this problem. The mean APT-CEST signal is lower in tumors
with mutations than without IDH mutation in HGG group (Figure 3B). However, more
patients need to be recruited to reveal the correlation between WHO and IDH
mutation status.
Besides the preoperative grade prediction, for those
patients without lesion-enhancement in Gd-enhanced T1 image, the resection
margin is a dilemma for neurosurgeon. For the sake of enhancing the survival
time of patient, a radical resection of the lesion and adjacent edema even
normal brain tissue is obviously a right choice; meanwhile, as every brain
region presents a specific function, the radical surgery strategy will hugely
damage the normal function even sacrifice patients’ living quality. Thus, a new
concept of resection margin: metabolic margin may reach the balance of maximum resection
and function saving. In this case, we did a small exploration of multimodality
neuro-navigational guided biopsy, trying to expose the possible margin and
furtherly confirm that. In our next step, we will recruit more patients to
modify our preoperative metabolic margin and make efforts to reach the maximum
resection with function ensuring via the aids of APT CEST imaging 7T.Acknowledgements
No acknowledgement found.References
1.
Holdhoff M. “Role of Molecular Pathology in the Treatment of Anaplastic Gliomas
and Glioblastomas.” J Natl Compr Canc Netw. 2018;16(5S):642-645.
2.
NCCN, NCCN Clinical Practice Guidelines in Oncology: Central Nervous System
Cancers (Version 3.2019). 2019.
3.
Zhou, J., et al., “Practical data acquisition method for human brain tumor
amide proton transfer (APT) imaging.” Magn Reson Med, 2008. 60(4): p. 842-9.
4.
Windschuh, Johannes, et al. "Correction of B1‐inhomogeneities for
relaxation‐compensated CEST imaging at 7 T." NMR in biomedicine 28.5
(2015): 529-537.
5.
Waitkus MS, Diplas BH, Yan H. “Biological Role and Therapeutic Potential of IDH
Mutations in Cancer.” Cancer Cell. 2018;34(2):186-195.